DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
16.50
+0.25 (1.54%)
May 29, 2026, 3:00 PM CST
-8.03% (1Y)
| Market Cap | 18.79B -11.2% |
| Revenue (ttm) | 27.52B +3.1% |
| Net Income | 1.29B +31.8% |
| EPS | 1.13 +30.8% |
| Shares Out | 1.14B |
| PE Ratio | 14.63 |
| Forward PE | 13.63 |
| Dividend | 0.98 (5.94%) |
| Ex-Dividend Date | n/a |
| Volume | 4,862,903 |
| Open | 16.25 |
| Previous Close | 16.25 |
| Day's Range | 16.23 - 16.68 |
| 52-Week Range | 15.34 - 21.78 |
| Beta | 0.62 |
| Analysts | Buy |
| Price Target | 24.49 (+48.42%) |
| Earnings Date | Apr 24, 2026 |